Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Plos Neglected Tropical Diseases
|
September 26, 2014
Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins
Daniel Wan, Fernanda Ludolf, Daniel G W Alanine, et al.
Basic & Clinical Pharmacology & Toxicology
|
February 27, 2018
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species
Grasiele de Sousa Vieira Tavares, Débora Vasconcelos Costa Mendonça, Daniela Pagliara Lage, et al.
Molecular Immunology
|
July 9, 2016
A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection
Mariana C Duarte, Daniela P Lage, Vívian T Martins, et al.
Parasitology Research
|
December 18, 2017
Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species
Débora Vasconcelos Costa Mendonça, Daniela Pagliara Lage, Stephane Lima Calixto, et al.
Experimental Parasitology
|
July 19, 2016
Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis
Débora V C Mendonça, Letícia M R Lage, Daniela P Lage, et al.
Immunobiology
|
October 4, 2016
A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection
Mariana Costa Duarte, Daniela Pagliara Lage, Vívian Tamietti Martins, et al.
Cytokine
|
August 25, 2018
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis
Patrícia A F Ribeiro, Daniel S Dias, Marcus V M Novais, et al.
Pathogens (Basel, Switzerland)
|
August 28, 2025
Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine
Marina F N Melo, Rômulo C D Lira, Raquel S B Câmara, et al.
Scientific Reports
|
March 17, 2023
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies
Fernanda F Ramos, Flávia F Bagno, Paula F Vassallo, et al.
Acta Tropica
|
July 15, 2023
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice
Daniela P Lage, Vívian T Martins, Danniele L Vale, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Plos Neglected Tropical Diseases
|
September 26, 2014
Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins
Daniel Wan, Fernanda Ludolf, Daniel G W Alanine, et al.
Basic & Clinical Pharmacology & Toxicology
|
February 27, 2018
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species
Grasiele de Sousa Vieira Tavares, Débora Vasconcelos Costa Mendonça, Daniela Pagliara Lage, et al.
Molecular Immunology
|
July 9, 2016
A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection
Mariana C Duarte, Daniela P Lage, Vívian T Martins, et al.
Parasitology Research
|
December 18, 2017
Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species
Débora Vasconcelos Costa Mendonça, Daniela Pagliara Lage, Stephane Lima Calixto, et al.
Experimental Parasitology
|
July 19, 2016
Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis
Débora V C Mendonça, Letícia M R Lage, Daniela P Lage, et al.
Immunobiology
|
October 4, 2016
A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection
Mariana Costa Duarte, Daniela Pagliara Lage, Vívian Tamietti Martins, et al.
Cytokine
|
August 25, 2018
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis
Patrícia A F Ribeiro, Daniel S Dias, Marcus V M Novais, et al.
Pathogens (Basel, Switzerland)
|
August 28, 2025
Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine
Marina F N Melo, Rômulo C D Lira, Raquel S B Câmara, et al.
Scientific Reports
|
March 17, 2023
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies
Fernanda F Ramos, Flávia F Bagno, Paula F Vassallo, et al.
Acta Tropica
|
July 15, 2023
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice
Daniela P Lage, Vívian T Martins, Danniele L Vale, et al.
Page
of 8